Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry

Fertility and Sterility

Volumn 88, Issue 1, 2007, Pages 145-151

  Zhao, Shuyun ^a,b   Qiao, Jie ^a   Li, Meizhi ^a   Zhang, Xiaowei ^a   Yu, Jiekai ^c   Li, Rong ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

insulin resistance; Polycystic ovary syndrome; protein profile; surface enhanced laser adsorption ionization time of flight mass spectrometry; weak cation exchange protein chip

Indexed keywords

PROTEIN;

ADULT; ARTICLE; BIOINFORMATICS; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HUMAN; INSULIN RESISTANCE; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; PROTEIN ARRAY ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34347255352     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.207     Document Type: Article

References (24)

1. Azziz R., Yildiz B., Woods K.S., Reyna R., Key T.J., Stephens K.C., et al. The prevalence of polycystic ovary syndrome among unselected consecutive premenopausal women. J Clin Endocrinol Metab 89 (2004) 2745-2749
2. Homburg R. Polycystic ovary syndrome in adolescence: new insights in pathophysiology and treatment. Endocr Dev 8 (2005) 137-149
3. Glueck C.J., Wang P., Goldenberg N., and Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 17 (2002) 2858-2864
4. The Rotterdam ESHRE/ASRM-Sponsored PCOS Work Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
5. Ovalle F., and Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 77 (2002) 1095-1105
6. Hanash S. Disease proteomics. Nature 422 (2003) 226-232
7. Issaq H.J., Veenstra T.D., Conrads T.P., and Felschow D. Breakthroughs and views: The SELDI-TOF MS approach to proteomics: protein profiling and biomarkers identification. Biochem Biophys Res Commun 292 (2002) 587-592
8. Bako A.U., Morad S., and Atiomo W.A. Polycystic ovary syndrome: an overview. Rev Gynaecol Pract 5 (2005) 115-122
9. Xing X.Y., Yang W.Y., and Yang Z.J. The diagnostic significance of homeostasis model assessment of insulin resistance in metabolic syndrome among subjects with different glucose tolerance. Chinese Journal of Diabetes 12 (2004) 182-186
10. Tai E.S., Lim S.C., Chew S.K., Tan B.Y., and Tan C.E. Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey. Diabetes Res Clin Pract 49 (2000) 159-168
11. Cortes C., and Vapnik V. Support vector network. Mach Learn 20 (1995) 273-297
12. Lee Y., and Lee C.K. Classification of multiple cancer types by multicategory support vector machines using gene expression data. Bioinformatics 19 (2003) 1132-1139
13. Liotta L.A., Ferrari M., and Petricoin E.F. Written in blood. Clinical proteomics. Nature 425 (2003) 905
14. Dayal B., and Ertel N.H. ProteinChip technology: a new and facile method for the identification and measurement of high density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease. J Proteome Res 1 (2002) 375-380
15. Plebani M. Proteomics: the next revolution in laboratory medicine?. Clin Chim Acta 357 (2005) 113-122
16. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
17. Brewer H.B. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 83 (1999) 3F-12F
18. Shachter N.S. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12 (2001) 297-304
19. Urbanek M., Legro R.S., Driscoll D.A., Azziz R., Ehrmann D.A., Norman J., et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci 96 (1999) 8573-8578
20. Rocken C., Ebert M.P., and Roessner A. Proteomics in pathology, research and practice. Pathol Res Pract 200 (2004) 69-82
21. Kozak K.R., Su F., Whitelegge J.P., Faull K., Reddy S., and Farias-Eisner R. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 5 (2005) 4589-4596
22. Malik G., Ward M.D., Gupta S.K., Trosset M.W., Grizzle W.E., Adam B.L., et al. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res 11 (2005) 1073-1085
23. Omenn G.S., States D.J., Adamski M., Blackwell T.W., Menon R., Hermjakob H., et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5 (2005) 3226-3245
24. Steel L.F., Haab B.B., and Hanash S.M. Methods of comparative proteomic profiling for disease diagnostics. J Chromatogr B 815 (2005) 275-284